ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$26.22
+0.85%
Mkt Cap $4.35B
Analyst Ratings
Buy
15
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
Implied Upside
+30.9%
Consensus $34.33 vs current $26.22
NASDAQ·Healthcare·Biotechnology
$26.22
+0.85%
Mkt Cap $4.35B
Buy
15
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
+30.9%
Consensus $34.33 vs current $26.22